Board-certified in internal medicine and ophthalmology, Dr. George Papaliodis specializes in the treatment of systemic diseases that are associated with ocular inflammation. As the director of the Ocular Immunology and Uveitis Service, he treats patients with a range of ocular inflammatory disorders at Mass. Eye and Ear's main Charles Street campus and Stoneham satellite office, as well at Massachusetts General Hospital. In addition, as a member of the Comprehensive Ophthalmology and Cataract Consultation Service, he performs cataract surgery at Mass. Eye and Ear's Charles Street location.
Dr. Papaliodis earned his medical degree and completed an ophthalmology residency at the University of Texas Southwestern School of Medicine. He went on to complete an additional residency in Internal Medicine at Harvard Medical School/Massachusetts General Hospital, followed by subspecialty training in ocular immunology and uveitis at Mass. Eye and Ear.
While most of his time is devoted to patient care, Dr. Papaliodis has been involved in a number of research projects, including an investigation of LX-211 for the treatment of inflammatory eye diseases and a study of pulsed electromagnetic field therapy for the treatment of uveitis. He also investigated serum biomarkers in ocular sarcoidosis and was part of the Abbvie sponsored study evaluating Humira for the treatment of uveitis.
A renowned expert in ocular inflammatory diseases, Dr. Papaliodis has presented at many national and international conferences, including those hosted by the International Ocular Inflammation Society, the American College of Rheumatology, the Aegean Retina Society, the New England Ophthalmologic Society, the North Carolina Dermatology Society, the Dominican Republic National Ophthalmologic Society, the Association for Research in Vision and Ophthalmology, and SECO International.
In addition to establishing one of the largest ocular inflammatory disease practices in the country, he has played a critical role outlining the teaching curriculum in the field of uveitis/ocular inflammation for the residents at Harvard Medical School.
Uveitis, systemic diseases with ophthalmologic manifestations, corneal disease, cataracts
Inflammatory eye diseases
Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis. William M, Faez S, Papaliodis GN, Lobo AM. J Ophthalmic Inflamm Infect. 2012 Dec;2(4):231-3.
Treatment of seronegative spondyloarthropathy-associated uveitis with golimumab: retrospective case series. Faez S, Lobo AM, Sobrin L, Papaliodis GN. Clin Experiment Ophthalmol. 2014 May-Jun;42(4):392-5.
Role of OCT in the diagnosis and management of macular edema from uveitis. Hunter RS, Skondra D, Papaliodis G, Sobrin L. Semin Ophthalmol. 2012 Sep-Nov;27(5-6):236-41.
Eales' Disease. Papaliodis GN. [Online publication, Uptodate.com]. 2011-present
Paraneoplastic conjunctival cicatrization: two different pathogenic types. Ahuero AE, Jakobiec FA, Bhat P, Ciralsky JB, Papaliodis GN. Ophthalmology. 2010 Apr;117(4):659-64.
View a list of publications on pubmed.gov>>
To learn more about Dr. Papaliodis, click here to read his "Meet a Specialist" profile.